JOURNAL OF DRUG TARGETING, cilt.26, sa.1, ss.66-74, 2018 (SCI-Expanded)
Purpose: The aim of this study is to test folate-conjugated cyclodextrin nanoparticles (FCD-1 and FCD-2) as a vehicle for reducing toxicity and increasing the antitumor efficacy of paclitaxel especially for metastatic breast cancer.